LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

Clinical trial NCT01986426 · COMPLETED

Trial details

NCT number: NCT01986426
Sponsor: Lytix Biopharma AS
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Melanoma Breast Cancer Head and Neck Cancer Lymphoma Triple-Negative Breast Cancer

Start date: 2013-11-01
Primary completion: 2018-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.